Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Ono Pharmaceutical Co. (OPHLF : OTC)

• Company Description    Ono Pharmaceuticals produces, purchases and sells pharmaceuticals and diagnostic reagents focusing primarily on prescription pharmaceuticals. Number of Employees: 3,853

• Price / Volume Information    Yesterday's Closing Price: $12.05 Daily Weekly Monthly 20 Day Moving Average: 1,050 shares Shares Outstanding: 469.71 (millions) Market Capitalization: $5,659.98 (millions) Beta: 0.19 52 Week High: $14.95 52 Week Low: $9.20 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 10.10% 8.16% 12 Week 12.51% 2.20% Year To Date 25.52% 12.07%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 8-2 Kyutaromachi 1-chome Chuo-ku - Osaka,M0 541-8564 JPN ph: 816-6263-5670 fax: 816-6263-2950 None http://www.ono-pharma.com

• General Corporate Information    Officers Akira Sagara - Chief Executive Officer; Chairman and Director Takino Toichi - Chief Operating Officer; President and Director Akihiro Tsujinaka - Executive Vice President and Director Masao Nomura - Director Akiko Okuno - Director Peer Information Ono Pharmaceutical Co. (GSAC) Ono Pharmaceutical Co. (CASI) Ono Pharmaceutical Co. (ALCD.) Ono Pharmaceutical Co. (OMNN) Ono Pharmaceutical Co. (CGPI.) Ono Pharmaceutical Co. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: J61546115 SIC: 2834 Fiscal Year Fiscal Year End: March Last Reported Quarter: 06/01/25 Next Expected EPS Date: 10/30/25 Share - Related Items Shares Outstanding: 469.71 Most Recent Split Date: 3.00 (5.00:1) Beta: 0.19 Market Capitalization: $5,659.98 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 10/30/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 19.44 PEG Ratio: - Price Ratios Price/Book: 1.05 Price/Cash Flow: 11.18 Price / Sales: 1.70 EPS Growth vs. Year Ago Period: -23.53% vs. Previous Quarter: 388.89% Sales Growth vs. Year Ago Period: 16.95% vs. Previous Quarter: 19.84% ROE 06/30/25 - 5.47 03/31/25 - 6.20 12/31/24 - 9.10 ROA 06/30/25 - 4.12 03/31/25 - 4.66 12/31/24 - 7.12 Current Ratio 06/30/25 - 2.99 03/31/25 - 3.07 12/31/24 - 3.55 Quick Ratio 06/30/25 - 2.44 03/31/25 - 2.56 12/31/24 - 2.91 Operating Margin 06/30/25 - 8.75 03/31/25 - 10.24 12/31/24 - 15.15 Net Margin 06/30/25 - 8.75 03/31/25 - 10.24 12/31/24 - 15.15 Pre-Tax Margin 06/30/25 - - 03/31/25 - 12.19 12/31/24 - - Book Value 06/30/25 - 11.43 03/31/25 - 11.07 12/31/24 - 11.54 Inventory Turnover 06/30/25 - - 03/31/25 - 2.30 12/31/24 - - Debt-to-Equity 06/30/25 - 0.13 03/31/25 - 0.13 12/31/24 - 0.14 Debt-to-Capital 06/30/25 - 11.13 03/31/25 - 11.76 12/31/24 - 12.05

Powered by Zacks Investment Research ©